Market Place
Sourcing Support
Bexion Chairman Charles Scheper Named Great Living Cincinnatian
06 Dec 2024 //
PR NEWSWIRE
Bexion Completes Enrollment in ASIST Study in mCRC
18 Nov 2024 //
PR NEWSWIRE
Bexion Pharma Receives Grant from Michael J. Fox Foundation
14 Nov 2024 //
PR NEWSWIRE
Bexion Pharma to Attend Jefferies London Healthcare Conference
12 Nov 2024 //
PR NEWSWIRE
Bexion Pharmaceuticals Announces Poster Presentation at SITC 2024
05 Nov 2024 //
PR NEWSWIRE
Bexion Pharma Publishes Phase 1 Data for BXQ-350 in Solid Tumors
31 Oct 2024 //
PR NEWSWIRE
Bexion Pharmaceuticals, Inc. to Present at BIO International Convention 2024
31 May 2024 //
PR NEWSWIRE
Bexion Pharmaceuticals Poster Presentation on BXQ-350 at AACR
10 Apr 2024 //
PR NEWSWIRE
Bexion Pharmaceuticals, Inc. Appoints Dr. Tariq Arshad as Chief Medical Officer
28 Feb 2024 //
PR NEWSWIRE
Bexion Pharmaceuticals, Inc. Announces Poster Presentation at ASCO GI 2024
16 Jan 2024 //
PR NEWSWIRE
Bexion Pharmaceuticals, Inc. to Present at Biotech Showcase 2024
05 Jan 2024 //
PR NEWSWIRE
Bexion to Participate in the 3rd Annual Needham Private Biotech Company
12 Oct 2023 //
PR NEWSWIRE
Bexion Appoints Dr. Catherine Pearce, DHSc, MBA, to Board of Directors
10 Oct 2023 //
PR NEWSWIRE
Bexion to Participate in the 2023 Cantor Global Healthcare Conference
25 Sep 2023 //
PR NEWSWIRE
Bexion Pharmaceuticals, Inc. to Present at the ESMO 2023
29 Jun 2023 //
PR NEWSWIRE
Bexion Pharma to Present at the 2023 American Association for AACR
15 Apr 2023 //
PR NEWSWIRE
Bexion to Present at the 22nd Annual Needham Virtual Healthcare Conference
11 Apr 2023 //
PR NEWSWIRE
Bexion doses first participant in trial of colorectal carcinoma therapy
11 Jan 2023 //
CLINICALTRIALSARENA
Bexion Pharmaceuticals, Inc. Welcomes New Chief Financial Officer
02 Jun 2022 //
PRNEWSWIRE
Bexion Pharmaceuticals Announces Leadership Additions
02 Feb 2022 //
PRNEWSWIRE
Bexion Pharmaceuticals Announces the Addition of Olivia F. Kirtley to BOD
22 Feb 2021 //
PRNEWSWIRE
Bexion Pharmaceuticals Presenting BXQ-350 Data at ASCO 2020
13 May 2020 //
PRNEWSWIRE
Bexion Pharma Receives Orphan Drug Designation for BXQ-350 for Malignant Glioma
07 May 2020 //
PRNEWSWIRE
Bexion Pharmaceuticals Increases Series B to $25MM
30 Apr 2019 //
PR NEWSWIRE
Bexion Pharmaceuticals Early-Stage Cancer Drug Being Hailed as Game Changer
10 Aug 2018 //
BIOSPACE
Bexion Pharmaceuticals Receives FDA Clearance for the First Clinical Trial
18 Jul 2016 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.